Fig. 1.
Pulmonary oedema and protein leakage after induction of transfusion-related acute lung injury and treatment with anti-CD40 ligand antibody or ciglitazone and controls. *P < 0·05; **P < 0·01.
Pulmonary oedema and protein leakage after induction of transfusion-related acute lung injury and treatment with anti-CD40 ligand antibody or ciglitazone and controls. *P < 0·05; **P < 0·01.